BG
ITCI

Bellevue Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,440,240
Closed -$204M 170
2024
Q4
$204M Sell
2,440,240
-45,387
-2% -$3.79M 3.92% 5
2024
Q3
$182M Buy
2,485,627
+14,342
+0.6% +$1.05M 2.95% 11
2024
Q2
$169M Sell
2,471,285
-348,197
-12% -$23.8M 2.75% 11
2024
Q1
$195M Sell
2,819,482
-246,918
-8% -$17.1M 2.98% 7
2023
Q4
$220M Sell
3,066,400
-103,850
-3% -$7.44M 3.36% 6
2023
Q3
$165M Sell
3,170,250
-31,550
-1% -$1.64M 2.66% 6
2023
Q2
$203M Sell
3,201,800
-66,200
-2% -$4.19M 2.89% 6
2023
Q1
$177M Sell
3,268,000
-74,236
-2% -$4.02M 2.57% 8
2022
Q4
$177M Buy
3,342,236
+12,957
+0.4% +$686K 2.35% 11
2022
Q3
$155M Sell
3,329,279
-20,100
-0.6% -$935K 2.22% 9
2022
Q2
$191M Sell
3,349,379
-80,240
-2% -$4.58M 2.7% 7
2022
Q1
$210M Sell
3,429,619
-199,300
-5% -$12.2M 2.44% 7
2021
Q4
$190M Sell
3,628,919
-145,000
-4% -$7.59M 1.96% 13
2021
Q3
$141M Buy
3,773,919
+164,000
+5% +$6.11M 1.43% 18
2021
Q2
$147M Sell
3,609,919
-50,000
-1% -$2.04M 1.44% 17
2021
Q1
$124M Hold
3,659,919
1.31% 22
2020
Q4
$116M Buy
3,659,919
+80,000
+2% +$2.54M 1.33% 23
2020
Q3
$91.9M Sell
3,579,919
-200,000
-5% -$5.13M 1.27% 22
2020
Q2
$97M Buy
3,779,919
+48,100
+1% +$1.23M 1.37% 15
2020
Q1
$57.4M Buy
3,731,819
+1,365,819
+58% +$21M 1.11% 24
2019
Q4
$81.2M Sell
2,366,000
-222,990
-9% -$7.65M 1.29% 22
2019
Q3
$19.3M Buy
2,588,990
+343,490
+15% +$2.57M 0.36% 62
2019
Q2
$29.1M Buy
+2,245,500
New +$29.1M 0.5% 50
2019
Q1
Sell
-52,600
Closed -$599K 149
2018
Q4
$599K Sell
52,600
-2,000
-4% -$22.8K 0.04% 129
2018
Q3
$1.19M Sell
54,600
-25,300
-32% -$549K 0.08% 121
2018
Q2
$1.41M Sell
79,900
-11,100
-12% -$196K 0.12% 105
2018
Q1
$1.92M Sell
91,000
-1,500
-2% -$31.6K 0.19% 83
2017
Q4
$1.34M Buy
92,500
+52,500
+131% +$760K 0.14% 97
2017
Q3
$631K Hold
40,000
0.07% 117
2017
Q2
$497K Buy
+40,000
New +$497K 0.06% 125